Show simple item record

dc.contributor.authorBruun, A.
dc.contributor.authorEnnis, D.
dc.contributor.authorWansbrough, H.
dc.contributor.authorGreen, Rachael
dc.contributor.authorMitchell, P.
dc.contributor.editorSteve Allsop
dc.contributor.editorNicole Lee
dc.identifier.citationBruun, A. and Ennis, D. and Wansbrough, H. and Green, R. and Mitchell, P. 2012. Treatment and care for young amphetamine-type stimulant users, in Allsop, S. and Lee, N. (ed), Perspectives on Amphetamine-Type Stimulants, pp. 277-293. Australia: IP Communications.

In the early to mid-2000s, researchers, policy-makers, and service providers began to respond to a dramatic increase in the prevalence of crystal methamphetamine use in the community (McKetin & McLaren 2004). The Australian media touted such trends as indicative of an 'epidemic' termed the 'ice age' (Carney 2006); however, more recent data indicate that rates of use may have declined. For example, an annual survey of Australian regular ecstasy users in 2007 found that 71 % of the sample had used any type of methamphetamine in the previous six months, compared to 54% in 2009 (Black et al 2008; Sindicich & Burns 2010). Despite this drop, methamphetamine continues to be one of the most commonly used illicit drugs among young people in our community (Cassar et al 2009; Sindicich & Burns 2010). In this chapter we investigate how service providers and practitioners can best respond to the particular needs of those young people whose use of amphetamine-type stimulants (ATS), particularly methamphetamine, has become dependent and problematic.

dc.publisherIP Communications
dc.titleTreatment and care for young amphetamine-type stimulant users
dc.typeBook Chapter
dcterms.source.titlePerspectives on Amphetamine-Type Stimulants
curtin.departmentNational Drug Research Institute (NDRI)
curtin.accessStatusFulltext not available

Files in this item


This item appears in the following Collection(s)

Show simple item record